Biocentry
Hematology-focused VC fund expects deal flow from inside, outside NYBC
MAY 11, 2023
$50M fund launched by New York Blood Center has already begun investing, typically as a syndicate partner
A new fund launched by New York Blood Center is aiming to be a syndicate partner for VCs investing in innovative blood products, including therapeutics developers and cell therapy manufacturers.